{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:05:03Z","timestamp":1781625903064,"version":"3.54.5"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E26\/200.145\/2023 and E-26\/210.521\/2019"],"award-info":[{"award-number":["E26\/200.145\/2023 and E-26\/210.521\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["426916\/2018-2"],"award-info":[{"award-number":["426916\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>Chronic liver disease (CLD) is a widespread condition and liver fibrosis is a common hallmark. The COVID-19 pandemic has drawn awareness over emerging pathogens that pose severe risks for chronic disease patients, whose management is complicated because most drugs can overload liver metabolism, therefore therapeutic alternatives are needed. Aims: based on the difficulty of treating CLD patients during respiratory infections, this study focused on the therapeutic evaluation of adipose-derived mesenchymal stromal cell (ASC) secretome. Methods: the effects of ASC secretome were evaluated in a preclinical murine model of liver fibrosis induced by thioacetamide (TAA) and acute lung injury induced by lipopolysaccharide, using histological and cytokine profile analyses. ASC secretome exhibited therapeutic effects alleviating fibrogenesis and inflammation, decreasing plasmatic inflammatory markers (cytokines IL-6, IL-17A and TNF-\u03b1), and restoring immune homeostasis. The secretome reduced liver collagen accumulation and IL-6 levels and restored lung cytoarchitecture, decreasing levels of CD68 and TNF-\u03b1. These results provide a preclinical basis for potential clinical use of the ASC secretome and its products, advancing the concept of cell-free, systemically active interventions for complex tissue injuries, and reinforcing the potential of its paracrine factors to modify pathological responses and promote tissue regeneration in combined chronic-acute diseases.<\/jats:p>","DOI":"10.3389\/ebm.2025.10782","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:10:09Z","timestamp":1759209009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic effects of mesenchymal stromal cell secretome in liver fibrosis with acute lung injury"],"prefix":"10.3389","volume":"250","author":[{"given":"Ane Caroline Ribeiro Novaes","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Ribeiro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina de Souza","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Claudino","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia Rosa","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f4nica","family":"Aiceles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Afonso Costa","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Alves","family":"Thole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Nunes","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100653","DOI":"10.1016\/j.aohep.2021.100653","article-title":"Management of COVID-19 patients with chronic liver diseases and liver transplants","volume":"27","author":"Hu","year":"2022","journal-title":"Ann Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e13338","DOI":"10.1111\/eci.13338","article-title":"COVID\u201019 and non\u2010alcoholic fatty liver disease: two intersecting pandemics","volume":"50","author":"Portincasa","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ueg2.12232","article-title":"COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: results from the multinational LEOSS registry","volume":"10","author":"Brozat","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/hep.31684","article-title":"Liver disease and coronavirus disease 2019: from pathogenesis to clinical care","volume":"74","author":"Saviano","year":"2021","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.jceh.2021.10.052","article-title":"Predictors of in-hospital outcomes in patients with cirrhosis and coronavirus Disease-2019","volume":"12","author":"Elhence","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.17235\/reed.2020.7627\/2020","article-title":"Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection","volume":"113","author":"Guerra Veloz","year":"2021","journal-title":"Revista espanola de enfermedades digestivas"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/hep.31574","article-title":"Liver injury in liver transplant recipients with coronavirus disease 2019 (COVID-19): U.S. multicenter experience","volume":"72","author":"Rabiee","year":"2020","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/liv.14730","article-title":"Pathophysiological mechanisms of liver injury in COVID-19","volume":"41","author":"Nardo","year":"2021","journal-title":"Liver Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/hepr.13510","article-title":"Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies","volume":"50","author":"Parohan","year":"2020","journal-title":"Hepatol Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"210228","DOI":"10.5888\/pcd19.210228","article-title":"COVID-19 severity and mortality among chronic liver disease patients: a systematic review and meta-analysis","volume":"19","author":"Nagarajan","year":"2022","journal-title":"Prev Chronic Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.14218\/JCTH.2021.00055","article-title":"Cytokine storm of COVID-19 and its impact on patients with and without chronic liver disease","volume":"9","author":"Premkumar","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15938","DOI":"10.18632\/aging.103632","article-title":"Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.14309\/ajg.0000000000000280","article-title":"Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcrc.2010.08.020","article-title":"Respiratory impact of paracentesis in cirrhotic patients with acute lung injury","volume":"26","author":"Levesque","year":"2011","journal-title":"J Crit Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00268-011-1161-0","article-title":"Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases","volume":"35","author":"Yang","year":"2011","journal-title":"World J Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","article-title":"Mesenchymal stromal cells","volume":"13","author":"Keating","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/cells12162039","article-title":"Mesenchymal stromal cells: heterogeneity and therapeutical applications","volume":"12","author":"Ouzin","year":"2023","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1101\/gad.351069.123","article-title":"Mesenchymal stromal cells as conductors of adipose tissue remodeling","volume":"37","author":"Cannavino","year":"2023","journal-title":"Genes Dev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yexcr.2015.05.002","article-title":"Bone marrow mononuclear cell transplantation improves mitochondrial bioenergetics in the liver of cholestatic rats","volume":"336","author":"de Andrade","year":"2015","journal-title":"Exp Cell Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1124\/dmd.122.000958","article-title":"Mesenchymal stem cell fates in murine acute liver injury and chronic liver fibrosis induced by carbon tetrachloride","volume":"50","author":"Ma","year":"2022","journal-title":"Drug Metab Disposition"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0187970","DOI":"10.1371\/journal.pone.0187970","article-title":"Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice","volume":"12","author":"Pinheiro","year":"2017","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3390\/cells8111339","article-title":"Mechanisms underlying cell therapy in liver fibrosis: an overview","volume":"8","author":"Pinheiro","year":"2019","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Development"},{"key":"B28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12967-020-02380-2","article-title":"Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients","volume":"18","author":"Rogers","year":"2020","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41419-020-03034-3","article-title":"Mesenchymal stem cells reverse EMT process through blocking the activation of NF-\u03baB and hedgehog pathways in LPS-induced acute lung injury","volume":"11","author":"Xiao","year":"2020","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"119510","DOI":"10.1016\/j.lfs.2021.119510","article-title":"Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19","volume":"278","author":"Paris","year":"2021","journal-title":"Life Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1146835","DOI":"10.3389\/fcell.2023.1146835","article-title":"COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs)","volume":"11","author":"Soliman","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/0023677215573040","article-title":"Standard operating procedures in experimental liver research: thioacetamide model in mice and rats","volume":"49","author":"Wallace","year":"2015","journal-title":"Lab Anim"},{"key":"B33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10753-017-0677-3","article-title":"Saikosaponin a ameliorates LPS-induced acute lung injury in mice","volume":"41","author":"Du","year":"2018","journal-title":"Inflammation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2893.2010.01307.x","article-title":"The complex interrelationships between chronic lung and liver disease: a review","volume":"17","author":"Spagnolo","year":"2010","journal-title":"J Viral Hepat"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3390\/ijms22052717","article-title":"The role of hypoxia-induced mitogenic factor in organ-specific inflammation in the lung and liver: key concepts and gaps in knowledge regarding molecular mechanisms of acute or immune-mediated liver injury","volume":"22","author":"Pai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5858\/arpa.2015-0519-ra","article-title":"Acute lung injury: a clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Arch Pathol & Lab Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.33549\/physiolres.934602","article-title":"Acute lung injury - from pathophysiology to treatment","volume":"69","author":"Mokr\u00e1","year":"2020","journal-title":"Physiol Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3748\/wjg.v13.i47.6385","article-title":"Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors","volume":"13","author":"Zhang","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3748\/wjg.v24.i12.1285","article-title":"Review article: update on current and emergent data on hepatopulmonary syndrome","volume":"24","author":"Soulaidopoulos","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jmcb\/mjaa067","article-title":"SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity","volume":"12","author":"Petruk","year":"2020","journal-title":"J Mol Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1586\/ers.10.71","article-title":"The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine","volume":"4","author":"Chen","year":"2010","journal-title":"Expert Rev Respir Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/molecules28030967","article-title":"Saikosaponin A and its epimers alleviate LPS-induced acute lung injury in mice","volume":"28","author":"Peng","year":"2023","journal-title":"Molecules"},{"key":"B44","doi-asserted-by":"publisher","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","article-title":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway","volume":"113","author":"Ye","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1080\/15548627.2017.1356550","article-title":"Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling","volume":"13","author":"Chen","year":"2017","journal-title":"Autophagy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/sctm.21-0021","article-title":"Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells","volume":"10","author":"Wang","year":"2021","journal-title":"Stem Cells Translational Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/ijn.s407029","article-title":"Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases","volume":"18","author":"Yuan","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/diagnostics10120999","article-title":"Clinical applications of mesenchymal stem\/stromal cell derived extracellular vesicles: therapeutic potential of an acellular product","volume":"10","author":"Massa","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5483\/bmbrep.2020.53.8.121","article-title":"Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment","volume":"53","author":"Jayaramayya","year":"2020","journal-title":"BMB Rep"},{"key":"B50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00418-010-0746-2","article-title":"Decreased collagen types I and IV, laminin, CK-19 and \u03b1-SMA expression after bone marrow cell transplantation in rats with liver fibrosis","volume":"134","author":"Carvalho","year":"2010","journal-title":"Histochem Cell Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/jcm9030682","article-title":"MSC based therapies\u2014new perspectives for the injured lung","volume":"9","author":"Behnke","year":"2020","journal-title":"J Clin Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/cpr.13028","article-title":"Immunosuppressive effect of mesenchymal stem cells on lung and gut CD8 + T cells in lipopolysaccharide\u2010induced acute lung injury in mice","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif"},{"key":"B53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14712598.2020.1689954","article-title":"Therapeutic potential of mesenchymal stem\/stromal cell-derived secretome and vesicles for lung injury and disease","volume":"20","author":"Liu","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10565-019-09493-5","article-title":"Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome","volume":"36","author":"Lopes-Pacheco","year":"2020","journal-title":"Cell Biol Toxicol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1244930","DOI":"10.3389\/fimmu.2023.1244930","article-title":"Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic","volume":"14","author":"Zhuang","year":"2023","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/resp.13127","article-title":"The association of non-alcoholic fatty liver disease with lung function: a survey design analysis using propensity score","volume":"23","author":"Kwak","year":"2018","journal-title":"Respirology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.cgh.2015.04.024","article-title":"The art and science of diagnosing and treating lung and heart disease secondary to liver disease","volume":"13","author":"Goldberg","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1002\/hep.31770","article-title":"Pulmonary abnormalities in liver disease: relevance to transplantation and outcome","volume":"74","author":"Raevens","year":"2021","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e94550","DOI":"10.1371\/journal.pone.0094550","article-title":"Pathophysiology of lung injury induced by common bile duct ligation in mice","volume":"9","author":"Shikata","year":"2014","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12906-022-03785-w","article-title":"Quercetin ameliorates acute lung injury in a rat model of hepatopulmonary syndrome","volume":"22","author":"Nassef","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerging Microbes & Infections"},{"key":"B62","doi-asserted-by":"publisher","first-page":"104645","DOI":"10.1016\/j.dci.2023.104645","article-title":"Interleukin-2 family cytokines: an overview of genes, expression, signaling and functional roles in teleost","volume":"141","author":"Zhang","year":"2023","journal-title":"Developmental & Comp Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2007.10.049","article-title":"Cytokines and anti-cytokines as therapeutics--an update","volume":"579","author":"Tayal","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-981-13-9367-9_4","article-title":"Interleukin-10 family cytokines immunobiology and structure","volume":"1172","author":"Wei","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"156268","DOI":"10.1016\/j.cyto.2023.156268","article-title":"Cytokines and their role as immunotherapeutics and vaccine adjuvants: the emerging concepts","volume":"169","author":"Rahman","year":"2023","journal-title":"Cytokine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"568","DOI":"10.4252\/wjsc.v13.i6.568","article-title":"Review of the potential of mesenchymal stem cells for the treatment of infectious diseases","volume":"13","author":"Sharma","year":"2021","journal-title":"World J Stem Cells"},{"key":"B67","first-page":"167","volume-title":"Role of L-Arginine in nitric oxide synthesis and health in humans","author":"Wu","year":"2021"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1161\/atvbaha.114.304398","article-title":"Homoarginine and cardiovascular outcome in the population-based Dallas heart study","volume":"34","author":"Atzler","year":"2014","journal-title":"Arteriosclerosis, Thromb Vasc Biol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/ijms18091852","article-title":"Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine","volume":"18","author":"Vizoso","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1002\/adma.201504009","article-title":"The exosome \u2010 A naturally secreted nanoparticle and its application to wound healing","volume":"28","author":"Rani","year":"2016","journal-title":"Adv Mater"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10782\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:10:10Z","timestamp":1759209010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10782\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":70,"alternative-id":["10.3389\/ebm.2025.10782"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2025.10782","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"article-number":"10782"}}